Peter Blume-Jensen - Insider Trading & Ownership

Entity
Individual
Location
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, Massachusetts
Summary
The estimated net worth of Peter Blume-Jensen is at least $24.1 M dollars as of May 16, 2024. Peter Blume-Jensen is the President and CEO, Director of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $24.1 M.
All Insider Reports
All Insider Reports

Ownership of Peter Blume-Jensen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACRV Acrivon Therapeutics, Inc. President and CEO, Director $24.1 M May 14, 2024

Insider Transactions Reported by Peter Blume-Jensen:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership